These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

753 related articles for article (PubMed ID: 19708783)

  • 41. Free-breathing quantitative dynamic contrast-enhanced magnetic resonance imaging in a rat liver tumor model using dynamic radial T(1) mapping.
    Braren R; Curcic J; Remmele S; Altomonte J; Ebert O; Rummeny EJ; Steingoetter A
    Invest Radiol; 2011 Oct; 46(10):624-31. PubMed ID: 21577121
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantification of renal perfusion: comparison of arterial spin labeling and dynamic contrast-enhanced MRI.
    Winter JD; St Lawrence KS; Cheng HL
    J Magn Reson Imaging; 2011 Sep; 34(3):608-15. PubMed ID: 21761490
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optimizing MRI scan time in the computation of pharmacokinetic parameters (K(trans) ) in breast cancer diagnosis.
    Jena A; Mehta SB; Taneja S
    J Magn Reson Imaging; 2013 Sep; 38(3):573-9. PubMed ID: 23349046
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reproducibility of perfusion parameters in dynamic contrast-enhanced MRI of lung and liver tumors: effect on estimates of patient sample size in clinical trials and on individual patient responses.
    Ng CS; Raunig DL; Jackson EF; Ashton EA; Kelcz F; Kim KB; Kurzrock R; McShane TM
    AJR Am J Roentgenol; 2010 Feb; 194(2):W134-40. PubMed ID: 20093564
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of analytical and numerical analysis of the reference region model for DCE-MRI.
    Lee J; Cárdenas-Rodríguez J; Pagel MD; Platt S; Kent M; Zhao Q
    Magn Reson Imaging; 2014 Sep; 32(7):845-53. PubMed ID: 24925838
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modeling of contrast agent kinetics in the lung using T1-weighted dynamic contrast-enhanced MRI.
    Naish JH; Kershaw LE; Buckley DL; Jackson A; Waterton JC; Parker GJ
    Magn Reson Med; 2009 Jun; 61(6):1507-14. PubMed ID: 19319896
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dynamic contrast-enhanced micro-computed tomography correlates with 3-dimensional fluorescence ultramicroscopy in antiangiogenic therapy of breast cancer xenografts.
    Pöschinger T; Renner A; Eisa F; Dobosz M; Strobel S; Weber TG; Brauweiler R; Kalender WA; Scheuer W
    Invest Radiol; 2014 Jul; 49(7):445-56. PubMed ID: 24598441
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantitative pharmacokinetic analysis of prostate cancer DCE-MRI at 3T: comparison of two arterial input functions on cancer detection with digitized whole mount histopathological validation.
    Fennessy FM; Fedorov A; Penzkofer T; Kim KW; Hirsch MS; Vangel MG; Masry P; Flood TA; Chang MC; Tempany CM; Mulkern RV; Gupta SN
    Magn Reson Imaging; 2015 Sep; 33(7):886-94. PubMed ID: 25683515
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intratumor heterogeneity in blood perfusion in orthotopic human melanoma xenografts assessed by dynamic contrast-enhanced magnetic resonance imaging.
    Gaustad JV; Benjaminsen IC; Graff BA; Brurberg KG; Ruud EB; Rofstad EK
    J Magn Reson Imaging; 2005 Jun; 21(6):792-800. PubMed ID: 15906326
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prediction of early response to radiotherapy of uterine carcinoma with dynamic contrast-enhanced MR imaging using pixel analysis of MR perfusion imaging.
    Takayama Y; Ohno T; Kishimoto R; Kato S; Yoneyama R; Kandatsu S; Tsujii H; Obata T
    Magn Reson Imaging; 2009 Apr; 27(3):370-6. PubMed ID: 18768283
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Automatic identification and classification of characteristic kinetic curves of breast lesions on DCE-MRI.
    Chen W; Giger ML; Bick U; Newstead GM
    Med Phys; 2006 Aug; 33(8):2878-87. PubMed ID: 16964864
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging.
    Ellingsen C; Egeland TA; Gulliksrud K; Gaustad JV; Mathiesen B; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):838-45. PubMed ID: 19215820
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
    Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
    Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An analysis of the pharmacokinetic parameter ratios in DCE-MRI using the reference region model.
    Lee J; Platt S; Kent M; Zhao Q
    Magn Reson Imaging; 2012 Jan; 30(1):26-35. PubMed ID: 22071409
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incorporating contrast agent diffusion into the analysis of DCE-MRI data.
    Pellerin M; Yankeelov TE; Lepage M
    Magn Reson Med; 2007 Dec; 58(6):1124-34. PubMed ID: 17969007
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reference region-based pharmacokinetic modeling in quantitative dynamic contract-enhanced MRI allows robust treatment monitoring in a rat liver tumor model despite cardiovascular changes.
    Steingoetter A; Svensson J; Kosanke Y; Botnar RM; Schwaiger M; Rummeny E; Braren R
    Magn Reson Med; 2011 Jan; 65(1):229-38. PubMed ID: 20872863
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparison of two methods for estimating DCE-MRI parameters via individual and cohort based AIFs in prostate cancer: a step towards practical implementation.
    Fedorov A; Fluckiger J; Ayers GD; Li X; Gupta SN; Tempany C; Mulkern R; Yankeelov TE; Fennessy FM
    Magn Reson Imaging; 2014 May; 32(4):321-9. PubMed ID: 24560287
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reproducibility of dynamic contrast-enhanced MR imaging. Part I. Perfusion characteristics in the female pelvis by using multiple computer-aided diagnosis perfusion analysis solutions.
    Heye T; Davenport MS; Horvath JJ; Feuerlein S; Breault SR; Bashir MR; Merkle EM; Boll DT
    Radiology; 2013 Mar; 266(3):801-11. PubMed ID: 23220897
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Classification of breast mass lesions using model-based analysis of the characteristic kinetic curve derived from fuzzy c-means clustering.
    Chang YC; Huang YH; Huang CS; Chang PK; Chen JH; Chang RF
    Magn Reson Imaging; 2012 Apr; 30(3):312-22. PubMed ID: 22245697
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Liver dynamic contrast-enhanced MRI for staging liver fibrosis in a piglet model.
    Zhou L; Chen TW; Zhang XM; Yang Z; Tang HJ; Deng D; Zeng NL; Wang LY; Chen XL; Li H; Li CP; Li L; Xie XY; Hu J
    J Magn Reson Imaging; 2014 Apr; 39(4):872-8. PubMed ID: 24123400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.